Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Vulvar Neoplasms 2 Melanoma 2 Liver Metastases 2 Ulcer 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pathologic Processes 1 Pancreatic Neoplasms 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma, Cutaneous Malignant 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gynecological Cancers 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Breast Cancer Female 1

Interventions

Tamoxifen 3 pyrotinib 2 abemaciclib 2 Metformin 2 Letrozole 2 Exercise 2 Cyclophosphamide 2 Control Groups 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 palbociclib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Cancer Female × Electrochemotherapy × Clear all

NCT06709937 2024-11-29

GISEL

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡